Curetis Unveils Rapid Diagnostic For Implant And Tissue Infections
Executive Summary
Curetis AG and its partner Heraeus Medical are ramping up for the European launch of a new molecular diagnostics assay designed to rapidly detect implant and tissue infections, including those associated with joint replacement surgery. The test will deliver a clinically actionable result in only four to five hours, compared with 10 days to two weeks for a microbiology culture.